Clinical Trial Update: A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) [EARLY_Phase 1]

View source ↗

Summary

Phase I/II study of Fragmented Autoantigen Stimulated T-cell-immunotherapy (FAST-CR) combined with radiotherapy. The trial targets breast cancer, colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Melanoma

Drugs mentioned

• FAST-CR (Fragmented Autoantigen Stimulated T-cell-immunotherapy) (Fragmented Autoantigen Stimulated T-cell-immunotherapy)

Snippet

Sponsor: Fengming Kong | Conditions: Breast Cancer, Colorectal Cancer, Melanoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING